Company: LENZ
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001193125-25-100630
Chunk: 92

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 92
---
 THE SHARES REPRESENTED BY THIS PROXY WILL BE VOTED AS DIRECTED OR, IF NO DIRECTION IS GIVEN, SHARES WILL BE VOTED IDENTICAL TO THE BOARD OF DIRECTORS RECOMMENDATION. This proxy, when properly executed, will be voted in the manner directed herein. In their discretion, the Named Proxies are authorized to vote upon such other matters that may properly come before the meeting or any adjournment or postponement thereof. You are encouraged to specify your choice by marking the appropriate box (SEE REVERSE SIDE) but you need not mark any box if you wish to vote in accordance with the Board of Directors’ recommendation. The Named Proxies cannot vote your shares unless you sign (on the reverse side) and return this card. PLEASE BE SURE TO SIGN AND DATE THIS PROXY CARD AND MARK ON THE REVERSE SIDE Copyright © 2025 BetaNXT, Inc. or its affiliates. All Rights Reserved

| LENZ Therapeutics, Inc. Annual Meeting of Stockholders |

| Please make your marks like this: |

| FOR EACH OF THE NOMINEES LISTED IN PROPOSAL 1 AND FOR PROPOSAL 2 |

|                                                                                                                                                                                                                                                             |     |     |     |           |     |         |     | BOARD OF   |
|                                                                                                                                                                                                                                                             |     |     |     |           |     |         |     | DIRECTORS  |
| PROPOSAL                                                                                                                                                                                                                                                    |     |     |     | YOUR VOTE |     |         |     | RECOMMENDS |
| 1.  To elect two Class III directors to hold office until our 2027 annual meeting of stockholders and two Class I directors to hold office until our 2028 annual meeting of stockholders, each until their respective successors are elected and qualified. |     |     |     |           |     |         |     |            |
|                                                                                                                                                                                                                                                             |     | FOR |     | WITHHOLD  |     |         |     |            |
| Class III:                                                                                                                                                                                                                                                  |     |     |     |           |     |         |     |            |
| 1.01 Kimberlee C. Drapkin                                                                                                                                                                                                                                   |     | ☐   |     | ☐         |     |         |     | FOR        |
| 1.02 Zach Scheiner                                                                                                                                                                                                                                          |     | ☐   |     | ☐         |     |         |     | FOR        |
| Class I: